设为首页 加入收藏

TOP

NESINA (alogliptin) tablets
2015-07-23 12:50:46 来源: 作者: 【 】 浏览:383次 评论:0
  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA.

    NESINA (alogliptin) tablets
    Initial U.S. Approval: 2013
     INDICATIONS AND USAGE

    NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1.1, 14)

    Limitation of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. (1.2)

    DOSAGE AND ADMINISTRATION
    The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily. ( 2.1)
    Can be taken with or without food. ( 2.1)
    Adjust dose if moderate or severe renal impairment or end-stage renal disease (ESRD). ( 2.2)

    Degree of Renal Impairment

    Creatinine Clearance (mL/min)

    以下是“全球医药”详细资料
  • Tags: 责任编辑:admin
    】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
    分享到QQ空间
    分享到: 
    上一篇Kanamycin Injection, USP 下一篇Evekeo(amphetamine sulfate tabl..

    相关栏目

    最新文章

    图片主题

    热门文章

    推荐文章

    相关文章

    广告位